| 000 | 01001 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250516033824.0 | ||
| 264 | 0 | _c20110902 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1520-5711 | ||
| 024 | 7 |
_a10.1080/10543406.2010.551325 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDmitrienko, Alex | |
| 245 | 0 | 0 |
_aSpecial issue for dealing with multiplicity in drug development: current state and new directions--guest editors' note. _h[electronic resource] |
| 260 |
_bJournal of biopharmaceutical statistics _cJul 2011 |
||
| 300 |
_a581-2 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Introductory Journal Article | ||
| 650 | 0 | 4 | _aBiostatistics |
| 650 | 0 | 4 |
_aDrug Discovery _xstatistics & numerical data |
| 650 | 0 | 4 |
_aPharmacogenetics _xstatistics & numerical data |
| 700 | 1 | _aPosch, Martin | |
| 773 | 0 |
_tJournal of biopharmaceutical statistics _gvol. 21 _gno. 4 _gp. 581-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10543406.2010.551325 _zAvailable from publisher's website |
| 999 |
_c20781618 _d20781618 |
||